| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $247K | -53.5% |
| Operating Income | $11.3M | — |
| Net Income | -$362K | +42.2% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35K | -69.9% |
| Current Assets | $43K | -65.4% |
| Total Assets | $43K | -65.4% |
| Current Liabilities | $295K | +21.9% |
| Total Liabilities | $295K | +21.9% |
| Stockholders' Equity | -$252K | -114.3% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82K | -8.8% |
| Financing Cash Flow | $174K | +0.0% |